Sorlandet Sykehus HF — Sponsor Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

0 Recruiting

0 Completed trials

1 Countries active

3 Unique IMPs

N/A Results reported

Phase III

Phase II/III

Top IMPs

2 total

IVIGSeN Pending

2022-501717-31-00 Phase II/III 1 country HUMAN NORMAL IMMUNOGLOBULIN; SODIUM CHLORIDE
An assessment of the effect of 1 dose with oxymetazoline nasal spray(Otrivin®) on the physical capacity of patients suffering from Chronic… Pending

2024-520177-12-00 Phase III 1 country XYLOMETAZOLINE HYDROCHLORIDE

Showing 1–2 of 2 trials